Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Evaluation of resistance training to improve muscular strength and body composition in cancer patients undergoing neoadjuvant and adjuvant therapy: a meta-analysis

Evaluation of resistance training to improve muscular strength and body composition in cancer... Purpose Muscle atrophy and strength decline are two of the vant therapy increased lower-limb muscular strength (mean: most prominent characteristics in cancer patients undergoing 26.22 kg, 95% CI [16.01, 36.43], heterogeneity: P =<0.01, cancer therapy, leading to decreased functional ability and I =76%, P = 0.00001) when compared to controls over time. reduced quality of life. Therefore, the aim is to systematically Similarly, lean body mass (LBM) increased (mean 0.8 kg, review research evidence of the effects of resistance exercise 95% CI [0.7, 0.9], heterogeneity: P =0.99, I =0%, (RE) on lower-limb muscular strength, lean body mass P < 0.00001), and decreased body fat (BF) (mean: −1.3 kg, (LBM), and body fat (BF) in cancer patients undertaking neo- 95% CI [−1.5, 1.1], heterogeneity: P = 0.93, I =0%, adjuvant or adjuvant therapy. P < 0.00001) compared to controls over time. Methods This research was conducted using the following Conclusion RE is effective to increase lower-limb muscular online database: Clinical Trial Register, Cochrane Trial strength, increase LBM, and decrease BF in cancer patients Register, PubMed, SPORT Discus, and SciELO, from undergoing neoadjuvant and adjuvant therapy regardless of September 2014 until May 2015. We used the following key- the kind of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Cancer Survivorship: Research and Practice Springer Journals

Evaluation of resistance training to improve muscular strength and body composition in cancer patients undergoing neoadjuvant and adjuvant therapy: a meta-analysis

Loading next page...
 
/lp/springer-journals/evaluation-of-resistance-training-to-improve-muscular-strength-and-fYpgBboWiw

References (65)

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer Science+Business Media New York
Subject
Medicine & Public Health; Public Health; Oncology; Health Promotion and Disease Prevention; Health Informatics; Quality of Life Research; Primary Care Medicine
ISSN
1932-2259
eISSN
1932-2267
DOI
10.1007/s11764-016-0592-x
pmid
28054255
Publisher site
See Article on Publisher Site

Abstract

Purpose Muscle atrophy and strength decline are two of the vant therapy increased lower-limb muscular strength (mean: most prominent characteristics in cancer patients undergoing 26.22 kg, 95% CI [16.01, 36.43], heterogeneity: P =<0.01, cancer therapy, leading to decreased functional ability and I =76%, P = 0.00001) when compared to controls over time. reduced quality of life. Therefore, the aim is to systematically Similarly, lean body mass (LBM) increased (mean 0.8 kg, review research evidence of the effects of resistance exercise 95% CI [0.7, 0.9], heterogeneity: P =0.99, I =0%, (RE) on lower-limb muscular strength, lean body mass P < 0.00001), and decreased body fat (BF) (mean: −1.3 kg, (LBM), and body fat (BF) in cancer patients undertaking neo- 95% CI [−1.5, 1.1], heterogeneity: P = 0.93, I =0%, adjuvant or adjuvant therapy. P < 0.00001) compared to controls over time. Methods This research was conducted using the following Conclusion RE is effective to increase lower-limb muscular online database: Clinical Trial Register, Cochrane Trial strength, increase LBM, and decrease BF in cancer patients Register, PubMed, SPORT Discus, and SciELO, from undergoing neoadjuvant and adjuvant therapy regardless of September 2014 until May 2015. We used the following key- the kind of

Journal

Journal of Cancer Survivorship: Research and PracticeSpringer Journals

Published: Jan 4, 2017

There are no references for this article.